CONTENTS

	Regulations
	Institutional Biosafety Committee
	Registration/Review of Research by the IBC

 I. Regulations
Revised regulations were issued by the National Institutes of Health (NIH) in April 1995 (59 FR 34496; 59 FR 40170; 60 FR 20726), titled "Guidelines for Research Involving Recombinant DNA Molecules." The purpose is to specify practices for constructing and handling recombinant DNA molecules and organisms and viruses containing recombinant DNA molecules. Copies of the federal guidelines are available at the Office of Research Services

II. Institutional Biosafety Committee (IBC)
The IBC currently has eight members, including two community representatives (see: http://academic.scranton.edu/department/ors/ibccomm.htm). The current chair is Michael Sulzinski, Ph.D., Biology. The IBC meets once a year and reviews research by mail year-round. Information on the status of the IBC is submitted annually to the Office of Recombinant DNA Activities, NIH.

III. Registration/Review of Research by the IBC
It is anticipated that most research conducted at the University will fall into categories which are exempt from review according to the NIH guidelines. However, all recombinant DNA research should be registered with the IBC using the "Registration Document for Recombinant DNA Research" which the committee has developed. Ten copies of this completed document and a one page description of the experimental methodology and containment procedures should be submitted to the Office of Research Services. Copies of the registration document are available at the Office of Research Services.